Chen X, Huang M, Fan D, He Y, Zhang W, Ding J
Nucleic Acids Res. 2024; 52(12):6811-6829.
PMID: 38676947
PMC: 11229315.
DOI: 10.1093/nar/gkae329.
Itonaga H, Mookhtiar A, Greenblatt S, Liu F, Martinez C, Bilbao D
Nat Commun. 2024; 15(1):3415.
PMID: 38649367
PMC: 11035800.
DOI: 10.1038/s41467-024-47689-4.
Xie Z, Tian Y, Guo X, Xie N
Cell Oncol (Dordr). 2024; 47(5):1503-1522.
PMID: 38619752
PMC: 11466993.
DOI: 10.1007/s13402-024-00943-9.
Ma Z, Lyu X, Qin N, Liu H, Zhang M, Lai Y
Genes Dis. 2023; 10(6):2383-2392.
PMID: 37554200
PMC: 10404874.
DOI: 10.1016/j.gendis.2022.05.021.
Coelho F, Gava S, Andrade L, Assis Geraldo J, Tavares N, Lunkes F
Front Microbiol. 2023; 14:1079855.
PMID: 36910171
PMC: 9998485.
DOI: 10.3389/fmicb.2023.1079855.
Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies.
Zhao A, Zhou H, Yang J, Li M, Niu T
Signal Transduct Target Ther. 2023; 8(1):71.
PMID: 36797244
PMC: 9935927.
DOI: 10.1038/s41392-023-01342-6.
The NFIB/CARM1 partnership is a driver in preclinical models of small cell lung cancer.
Gao G, Hausmann S, Flores N, Benitez A, Shen J, Yang X
Nat Commun. 2023; 14(1):363.
PMID: 36690626
PMC: 9870865.
DOI: 10.1038/s41467-023-35864-y.
Turning Nonselective Inhibitors of Type I Protein Arginine Methyltransferases into Potent and Selective Inhibitors of Protein Arginine Methyltransferase 4 through a Deconstruction-Reconstruction and Fragment-Growing Approach.
Iannelli G, Milite C, Marechal N, Cura V, Bonnefond L, Troffer-Charlier N
J Med Chem. 2022; 65(17):11574-11606.
PMID: 35482954
PMC: 9469100.
DOI: 10.1021/acs.jmedchem.2c00252.
Protein arginine methyltransferases: promising targets for cancer therapy.
Hwang J, Cho Y, Bae G, Kim S, Kim Y
Exp Mol Med. 2021; 53(5):788-808.
PMID: 34006904
PMC: 8178397.
DOI: 10.1038/s12276-021-00613-y.
Chromatin Modifiers in Transcriptional Regulation: New Findings and Prospects.
Mazina M, Vorobyeva N
Acta Naturae. 2021; 13(1):16-30.
PMID: 33959384
PMC: 8084290.
DOI: 10.32607/actanaturae.11101.
How Protein Methylation Regulates Steroid Receptor Function.
Malbeteau L, Pham H, Eve L, Stallcup M, Poulard C, Le Romancer M
Endocr Rev. 2021; 43(1):160-197.
PMID: 33955470
PMC: 8755998.
DOI: 10.1210/endrev/bnab014.
Transcriptional regulation by methyltransferases and their role in the heart: highlighting novel emerging functionality.
Szulik M, Davis K, Bakhtina A, Azarcon P, Bia R, Horiuchi E
Am J Physiol Heart Circ Physiol. 2020; 319(4):H847-H865.
PMID: 32822544
PMC: 7654657.
DOI: 10.1152/ajpheart.00382.2020.
CARM1 inhibition reduces histone acetyltransferase activity causing synthetic lethality in CREBBP/EP300-mutated lymphomas.
Veazey K, Cheng D, Lin K, Villarreal O, Gao G, Perez-Oquendo M
Leukemia. 2020; 34(12):3269-3285.
PMID: 32576962
PMC: 7688486.
DOI: 10.1038/s41375-020-0908-8.
Recent advances in targeting protein arginine methyltransferase enzymes in cancer therapy.
Smith E, Zhou W, Shindiapina P, Sif S, Li C, Baiocchi R
Expert Opin Ther Targets. 2018; 22(6):527-545.
PMID: 29781349
PMC: 6311705.
DOI: 10.1080/14728222.2018.1474203.
The arginine methyltransferase CARM1 represses p300•ACT•CREMτ activity and is required for spermiogenesis.
Bao J, Rousseaux S, Shen J, Lin K, Lu Y, Bedford M
Nucleic Acids Res. 2018; 46(9):4327-4343.
PMID: 29659998
PMC: 5961101.
DOI: 10.1093/nar/gky240.
Protein arginine methylation: an emerging regulator of the cell cycle.
Raposo A, Piller S
Cell Div. 2018; 13:3.
PMID: 29568320
PMC: 5859524.
DOI: 10.1186/s13008-018-0036-2.
Identification and structural analysis of protein arginine methyltransferase 4 (PRMT4).
Berberich H, Terwesten F, Rakow S, Sahu P, Bouchard C, Meixner M
FEBS Open Bio. 2017; 7(12):1909-1923.
PMID: 29226078
PMC: 5715347.
DOI: 10.1002/2211-5463.12323.
Structural and Functional Impacts of ER Coactivator Sequential Recruitment.
Yi P, Wang Z, Feng Q, Chou C, Pintilie G, Shen H
Mol Cell. 2017; 67(5):733-743.e4.
PMID: 28844863
PMC: 5657569.
DOI: 10.1016/j.molcel.2017.07.026.
Inhibitors of Protein Methyltransferases and Demethylases.
Umit Kaniskan H, Martini M, Jin J
Chem Rev. 2017; 118(3):989-1068.
PMID: 28338320
PMC: 5610952.
DOI: 10.1021/acs.chemrev.6b00801.
PARAQUAT TOLERANCE3 Is an E3 Ligase That Switches off Activated Oxidative Response by Targeting Histone-Modifying PROTEIN METHYLTRANSFERASE4b.
Luo C, Cai X, Du J, Zhao T, Wang P, Zhao P
PLoS Genet. 2016; 12(9):e1006332.
PMID: 27676073
PMC: 5038976.
DOI: 10.1371/journal.pgen.1006332.